PTH Among Health Care ETFs
End-of-day Nov 19, 2026 · 39 Health care ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −6.2% | −8.8% | −13.7% | +9.4% | +11.1% | +74.2% | +3.8% | +250.3% | +576.2% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$43 of every $1,000 in PTH is Roivant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ROIVRoivant Sciences | Healthcare | 4.32% | $432.22 | 300K | $11.6M |
| 2 | INSMInsmed | Healthcare | 4.12% | $411.84 | 93K | $11.1M |
| 3 | THCTenet Healthcare | Healthcare | 4.09% | $409.19 | 41K | $11.0M |
| 4 | GHGuardant Health | Healthcare | 3.43% | $343.44 | 64K | $9.2M |
| 5 | AXGNAxogen | Healthcare | 3.37% | $336.86 | 159K | $9.1M |
| 6 | RVMDRevolution Medicines | Healthcare | 3.25% | $325.27 | 55K | $8.8M |
| 7 | MEDPMedpace | Healthcare | 3.15% | $314.98 | 13K | $8.5M |
| 8 | TXG10X Genomics | Healthcare | 3.03% | $302.56 | 143K | $8.1M |
| 9 | HNGEHinge Health | Healthcare | 3.02% | $302.05 | 71K | $8.1M |
| 10 | EXELExelixis | Healthcare | 2.97% | $296.76 | 117K | $8.0M |
| 11 | NTRANatera | Healthcare | 2.92% | $291.56 | 27K | $7.8M |
| 12 | IOVAIovance Biotherapeutics | Healthcare | 2.76% | $276.20 | 994K | $7.4M |
| 13 | CDNACareDx | Healthcare | 2.54% | $253.51 | 92K | $6.8M |
| 14 | CRLCharles River Laboratories International | Healthcare | 2.51% | $250.64 | 20K | $6.7M |
| 15 | TWSTTwist Bioscience | Healthcare | 2.48% | $248.21 | 57K | $6.7M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ROIV | Roivant Sciences | 4.32% |
| 2 | INSM | Insmed | 4.12% |
| 3 | THC | Tenet Healthcare | 4.09% |
| 4 | GH | Guardant Health | 3.43% |
| 5 | AXGN | Axogen | 3.37% |
| 6 | RVMD | Revolution Medicines | 3.25% |
| 7 | MEDP | Medpace | 3.15% |
| 8 | TXG | 10X Genomics | 3.03% |
| 9 | HNGE | Hinge Health | 3.02% |
| 10 | EXEL | Exelixis | 2.97% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 26, 2025 | $1.53 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0255 |
| Dec 20, 2013 | Dec 31, 2013 | $0.0114 |
| Sep 20, 2013 | Sep 30, 2013 | $0.0027 |
| Jun 21, 2013 | Jun 28, 2013 | $0.0368 |
| Dec 21, 2012 | Dec 31, 2012 | $0.11 |
| Jun 15, 2012 | Jun 29, 2012 | $0.0084 |
| Dec 18, 2009 | Dec 31, 2009 | $0.0194 |
| Jun 19, 2009 | Jun 30, 2009 | $0.0083 |